Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1279-1287

  Li, Wei ^a   Ma, Qingyong ^a   Li, Junhui ^a   Guo, Kun ^a   Liu, Han ^a   Han, Liang ^a   Ma, Guodong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hydrogen peroxide; Hyperglycemia; Invasion; Migration; Pancreatic cancer

Indexed keywords

CATALASE; GLUCOSE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERGLYCEMIA; IN VITRO STUDY; METASTASIS POTENTIAL; OXIDATION REDUCTION REACTION; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; HYPERGLYCEMIA; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SUPEROXIDE DISMUTASE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 79953034924     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1150     Document Type: Article

References (35)

1. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N and Depinho RA: Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20: 1218-1249, 2006. (Pubitemid 43727584)
2. Wray CJ, Ahmad SA, Matthews JB and Lowy AM: Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128: 1626-1641, 2005. (Pubitemid 40692556)
3. Coughlin SS, Calle EE, Teras LR, Petrelli J and Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167, 2004. (Pubitemid 38747263)
4. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G and Kaaks R: Prospective study of hyperglycemia and cancer risk. Diabetes Care 30: 561-567, 2007. (Pubitemid 46354334)
5. Robertson R, Zhou H, Zhang T and Harmon JS: Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys 48: 139-146, 2007. (Pubitemid 47340880)
6. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H and Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
7. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I and Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000. (Pubitemid 30212409)
8. Sindhu RK, Koo JR, Roberts CK and Vaziri ND: Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin Exp Hypert 26: 43-53, 2004. (Pubitemid 38248221)
9. Abou-Seif MA and Youssef AA: Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346: 161-170, 2004. (Pubitemid 38901047)
10. Storz P: Mitochondrial ROS - radical detoxification, mediated by protein kinase D. Trends Cell Biol 17: 13-18, 2007.
11. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S and Husain SA: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59: 163-170, 2000. (Pubitemid 30216139)
12. Lewis A, Du J, Liu J, Ritchie JM, Oberley LW and Cullen JJ: Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin Exp Metastasis 22: 523-532, 2005. (Pubitemid 43234636)
13. Nishikawa M, Tamada A, Hyoudou K, Umeyama Y, Takahashi Y, Kobayashi Y, Kumai H, Ishida E, Staud F, Yabe Y, Takakura Y, Yamashita F and Hashida M: Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 21: 213-221, 2004. (Pubitemid 39158498)
14. Nishikawa M, Tamada A, Kumai H, Yamashita F and Hashida M: Inhibition of experimental pulmonary metastasis by controlling bio distribution of catalase in mice. Int J Cancer 99: 474-479, 2002. (Pubitemid 34495865)
15. Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP and Ellis LM: Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-1 receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res 65: 7775-7781, 2005. (Pubitemid 41297252)
16. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Hofler H, Janicke F and Graeff H: Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78: 285-296, 1997. (Pubitemid 27289256)
17. Lee KH and Kim JR: Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor. Exp Mol Med 41: 180-188, 2009.
18. Lee KH, Kim SW and Kim JR: Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. J Exp Clin Cancer Res 28: 73, 2009.
19. Rodriguez AM, Carrico PM, Mazurkiewicz JE and Melendez JA: Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H(2)O(2). Free Radic Biol Med 29: 801-813, 2000.
20. Krechler T, Novotny J, Zeman M, Krska Z, Svestka T, Svab J, Lukas M, Filipova R and Zak A: Pancreatic carcinoma and diabetes mellitus. Cas Lek Cesk 143: 97-100, 2004.
21. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM and Decamp MM: Factors associated with local and distant recurrence and survival in patients with resected non-small cell lung cancer. Cancer 115: 1059-1069, 2009.
22. Muehlenweg B, Sperl S, Magdolen V, Schmitt M and Harbeck N: Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours. Expert Opin Biol Ther 1: 683-691, 2001. (Pubitemid 33769079)
23. Nishikawa M, Hashida M and Takakura Y: Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 61: 319-326, 2009.
24. Ushio-Fukai M and Nakamura Y: Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52, 2008. (Pubitemid 351753035)
25. Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A, Belarmino J, van de Water L, Mian BM and Melendez JA: Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 67: 10260-10267, 2007. (Pubitemid 350070799)
26. Kozuki Y, Miura Y and Yagasaki K: Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 151: 111-115, 2000. (Pubitemid 30155592)
27. Kozuki Y, Miura Y and Yagasaki K: Inhibitory effect of curcumin on the invasion of rat ascites hepatoma cells in vitro and ex vivo. Cytotechnology 35: 57-63, 2001. (Pubitemid 32304977)
28. Kobayashi Y, Nishikawa M, Hyoudou K, Yamashita F and Hashida M: Hydrogen peroxide-mediated nuclear factor kappaB activation in both liver and tumor cells during initial stages of hepatic metastasis. Cancer Sci 99: 1546-1552, 2008.
29. Toh Y, Kuninaka S, Oshiro T, Ikeda Y, Nakashima H, Baba H, Kohnoe S, Okamura T, Mori M and Sugimachi K: Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol 17: 107-112, 2000.
30. Kattan Z, Minig V, Leroy P, Dauca M and Becuwe P: Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat 108: 203-215, 2008. (Pubitemid 351311363)
31. Hyoudou K, Nishikawa M, Kobayashi Y, Kuramoto Y, Yamashita F and Hashida M: Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase. Clin Exp Metastasis 23: 269-278, 2006.
32. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
33. Palmeira CM, Rolo AP, Berthiaume J, Bjork JA and Wallace KB: Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol 225: 214-220, 2007. (Pubitemid 350088064)
34. Yu T, Robotham JL and Yoon Y: Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103: 2653-2658, 2006.
35. Sawai H, Liu J, Reber HA, Hines OJ and Eibl G: Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. Mol Cancer Res 4: 159-167, 2006.